Trusted News Discovery Since 2008
{{/content}}
Covid vaccine: Covaxin phase 3 trials on 3,000 people in UP, says minister
Video Credit: HT Digital Content
Published on September 30, 2020 - Duration: 02:29s
Covid vaccine: Covaxin phase 3 trials on 3,000 people in UP, says minister
Hyderabad-based pharma company Bharat Biotech to conduct phase 3 clinical trial tests in October.
Uttar Pradesh Health Minister Jai Pratap Singh said around 3,000 people to be tested under the phase 3 trial of the vaccine candidate.
Bharat Biotech is working with the Indian Council of Medical Research (ICMR) to develop a vaccine candidate – Covaxin.
The pharma company recently signed an agreement with the Washington University School of Medicine for an intranasal single-dose vaccine.
Watch the full video for more details.
You are here
Related videos from verified sources
New promising results from Moderna vaccine trial 00:21
Video credit: KTNV Channel 13 Las Vegas - Published on September 30, 2020
Moderna and Regeneron Jump on Positive Covid-19 Vaccine Trials 02:37
Video credit: The Street - Published on September 30, 2020
Bharat Biotech will involve 3,000 people for phase-III trials of COVID vaccine in UP 01:36
Video credit: ANI - Published on September 30, 2020